SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 7th, 2020 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances • Delaware
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) dated July 1, 2020, is entered into by and between (i) Aspira Women’s Health Inc., a Delaware corporation (the “Company”), and (ii) the investor listed on Schedule I (including its successors and permitted assigns, the “Investor”). To the extent that there are multiple Investors listed on Schedule I, all references herein to “the Investor” shall refer to each such Investor, severally and not jointly.
